Laticort (Hydrocortisone Butyrate)

Hydrocortisone butyrate penetrates the skin and binds to glucocorticoid receptors inside cells. This binding alters gene expression, suppressing pro‑inflammatory cytokines and mediators while promoting anti‑inflammatory proteins, thereby decreasing local inflammation and immune activity.

The dosage of Laticort is determined by the prescribing clinician based on the severity of the skin condition, the area to be treated, and patient factors. Patients should follow the specific instructions provided by their healthcare professional.

Safety of Laticort in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their physician before using the product.

To order Laticort, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Laticort (hydrocortisone butyrate) is a medium‑potency corticosteroid, offering a balance between efficacy and safety. Compared with lower‑potency agents like hydrocortisone 1%, it provides stronger anti‑inflammatory action, while being less potent than high‑strength steroids such as clobetasol, which carry a higher risk of skin atrophy.

Laticort should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and extreme temperatures to maintain its stability and potency.

Laticort is applied topically to the affected skin area. A thin layer is spread gently over the lesion, usually once or twice daily, as directed by the prescriber. Hands should be washed before and after application to avoid accidental exposure.

Serious risks include skin atrophy, development of stretch marks (striae), hypopigmentation, and systemic effects such as adrenal suppression if used over large areas or for prolonged periods. Secondary infections may also occur, requiring prompt medical attention.

Laticort should be avoided in individuals with known hypersensitivity to hydrocortisone butyrate or any excipients, in patients with untreated skin infections, and in those where systemic corticosteroid therapy is contraindicated. Children, pregnant or lactating women should use it only under medical supervision.